Researchers from the Tokyo University of Science (TUS) have developed a thin, mucoadhesive film using xyloglucan and high-concentration green tea extract rich in catechins, including a significant percentage of epigallocatechin gallate (EGCG) to treat oral mucositis.
Oral mucositis results from the damage inflicted on rapidly dividing cells that make up the mucosal lining of the mouth, leading to agonizing lesions that necessitate urgent relief.
The formulation aims to introduce a simple yet effective solution for delivering active ingredients such as medications directly to the affected areas, promising a new level of convenience.
The researchers meticulously prepared two distinct types of films: hydrogels and xerogels. The xerogel exhibits substantial strength and resistance to detachment, making it highly suitable for prolonged application in oral situations where durability is essential.
The films’ xerogel-like characteristics promote rapid water absorption, an essential trait for the film’s performance in moist oral environments.
According to Professor Takehisa Hanawa from TUS, the combined strengths of these films offer a unique advantage, enabling not only efficient adhesion but also the ability to release beneficial compounds gradually—the perfect combination for treating delicate oral tissues.
Their studies also revealed that the films could steadily release EGCG when soaked in water, paving the way for the potential therapeutic application that could prolong patient comfort and reduce undesirable symptoms associated with oral mucositis.
The Tokyo University of Science remains aligned with its mission to foster innovation that supports sustainable health practices, aiming ultimately to enhance the standard of care in oncology.
The collaborative spirit seen in this study highlights the importance of interdisciplinary teamwork in scientific exploration, demonstrating the potential good that can come when diverse talents unite toward a common goal.
This pioneering work serves as a promising beacon of hope for those confronting the harsh realities of cancer treatment and oral mucositis.